Explore more publications!

Fintech Reporter UK: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Fintech Reporter UK.

Press releases published on November 18, 2025

Israel Launches Next Phase of National Drone Initiative, Paving the Way for Drone-Based Commercial Aerial Services
Mortgage Brokerage Services Market : Global Opportunity Analysis and Industry Forecast, 2023 - 2033
Fuel50 Recognized as a Strategic Challenger on the 2025 Fosway 9-Grid™ for Talent & People Success
Wilson Partners advises on sale of Cubic Interactive to Milient Software to support international growth
Li Auto Obtains First Overseas Whole-Vehicle Certification
Tern Rebrands as Tilly, Bringing Human Connection to AI-Powered Travel and Discovery
DiaGen AI Inc. and Metanova Labs Announce Joint Venture LOI to Develop Hit Picking Tool for Automating Drug Discovery
ShipToBox.com Announces Expansion of Its AI Global Checkout Platform
Travel Without Bags: Luggage To Ship (LuggageToShip.com) Launches New AI Travel Platform
InfraPartners and JLL team up to accelerate AI Data Center deployment and streamline operations
10ZiG Offers Migration Path for Omnissa Horizon PCoIP Users
PAA Joins Grenova’s Parent Company to Advance Lab Automation
New Book Shows How the Right Culture and Strategy Drive Breakthroughs in Drug and Device Development
UK MGA Century Underwriting secures Landmark Long-Term Capacity Partnership with Antares Insurance Company Limited
OpenDialog AI Appoints Paul Taylor as Chief Marketing Officer to Accelerate Brand Positioning and Commercial Growth
Modcon Systems Unveils AI-Integrated Analyzer Platform for Real-Time Process Optimization
B&H Worldwide Supports AerFin’s First A320neo Teardown in Asia-Pacific
Colle AI Deploys Smart Publishing Systems to Boost Real-Time Digital Asset Production
Transaction in Own Shares

Transaction in Own Shares

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions